3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Active not recruiting
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Esophageal Neoplasms
12
Esophageal Squamous Cell Carcinoma
7
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Head and Neck Neoplasms
3
Glioblastoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Hyperthermia
2
Anus Neoplasms
2
Adenocarcinoma
2
Unresectable Stage III NSCLC
1
Thymic epithelial tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Recurrence
1
Rare Diseases
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Metastasising Cancer of Unknown Primary
1
Medulloblastoma
1
Lymphoma, B-Cell, Marginal Zone
1
Locally Advanced Rectal Cancer
1
Interventions
Tamoxifen
3
Neoadjuvant Therapy
2
Amplified Fragment Length Polymorphism Analysis
2
Ultrasonography
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Polymerase Chain Reaction
1
Pharmacogenomic Testing
1
Mammography
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Immunoenzyme Techniques
1
Fulvestrant
1
DNA Methylation
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Intraductal, Noninfiltrating
×
Radiation
×
Clear all
NCT00470236
2023-03-22
DCIS
Trans Tasman Radiation Oncology Group
Phase NA
Unknown
1,608 enrolled